Sage Therapeutics, Inc.
C17, C20, and C21 substituted neuroactive steroids and their methods of use

Last updated:

Abstract:

Described herein are neuroactive steroids or a pharmaceutically acceptable salt thereof. Such compounds are envisioned, in certain embodiments, to behave as GABA modulators. Also provided are pharmaceutical compositions comprising a compound described herein and methods of use and treatment, e.g., such as for inducing sedation and/or anesthesia.

Status:
Grant
Type:

Utility

Filling date:

11 Jul 2017

Issue date:

26 Jul 2022